Literature DB >> 9863916

Tamoxifen-induced endometrial polyp. A case report and review of the literature.

I N Nomikos1, J Elemenoglou, J Papatheophanis.   

Abstract

A case of an endometrial polyp which developed in a 74-year-old woman treated with tamoxifen for 15 years after breast cancer surgery was the stimulus for this brief and concise review of the endometrial changes caused by anti-estrogen treatment in post-menopausal women with breast cancer. Tamoxifen therapy has been associated with the development of endometrial polyps, hyperplasia and adenocarcinoma possibly mediated through its agonistic estrogenic properties. Hysteroscopy follow-up should be performed in this group of patients and hysteroscopy should be done before the beginning of therapy and repeated once a year during the treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9863916

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  Story of a Giant Endometrial Polyp in Asymptomatic Postmenopausal Female.

Authors:  Jahnavi Meena; Rahul Manchanda; Sudhir Kulkarni; Nirmal Bhargava; Priyanka Mahawar
Journal:  J Clin Diagn Res       Date:  2017-03-01

2.  Oncogenic Potential and Clinical Implications of Giant Endometrial Polyps: A Case Report and Literature Review.

Authors:  Brittany van Staalduinen; Andrew Stahler; Catherine Abied; Rita Shats; Nisha A Lakhi
Journal:  Case Rep Obstet Gynecol       Date:  2018-06-07

3.  Giant Endometrial Polyp: An Enigma in a Postmenopausal Woman.

Authors:  Sonam Sharma
Journal:  J Midlife Health       Date:  2018 Oct-Dec

4.  Long-term comparisons of the efficacy, safety, and pregnancy outcomes of adjuvant tamoxifen plus ovarian function suppression in premenopausal Han and Zhuang Chinese patients with hormone receptor-positive early breast cancer.

Authors:  Shicong Tang; Qiong Zhang; Xianghui Tang; Dong Chen; Fan Zhang; Jianlun Liu; Wei Wei; Dequan Liu
Journal:  J Int Med Res       Date:  2018-10-25       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.